The present invention relates to cyclic indolizinecarboxamides and azaindolizinecarboxamides of the formulae Ia and Ib,
wherein R, R
a
, R
10
, R
20
, R
30
, R
40
, Y, n, p and q have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they inhibit the enzyme renin and modulate the activity of the renin-angiotensin system, and are useful for the treatment of diseases such as hypertension, for example. The invention furthermore relates to processes for the preparation of the compounds of the formulae Ia and Ib, their use and pharmaceutical compositions comprising them.
本发明涉及公式Ia和Ib的环状
吲哚啉羧酰胺和氮杂
吲哚啉羧酰胺,其中R、Ra、R10、R20、R30、R40、Y、n、p和q在权利要求中所示,它们是有价值的药物活性化合物。具体来说,它们抑制酶酰肽酶并调节肾素-
血管紧张素系统的活性,对于治疗高血压等疾病有用。此外,本发明还涉及制备公式Ia和Ib化合物的方法,以及它们的使用和含有它们的制药组合物。